source
- AstraZeneca halts phase 3 lung cancer trial of bispecific antibody volrustomig after it falls short of KeytrudaAstraZeneca stopped its phase 3 trial of the bispecific antibody volrustomig in metastatic non‑small cell lung cancer after interim data suggested the regimen would not meet the study's primary goa…
- FDA releases first updated guidance in 27 years on container and closure systems for drugs and biologicsThe FDA announced a draft guidance that updates the agency’s recommendations for evaluating container and closure systems used in the packaging of new drugs and biologics. This revision is the fir…